Euroapi S.A. (EPA:EAPI)

France flag France · Delayed Price · Currency is EUR
2.980
+0.012 (0.40%)
Sep 4, 2025, 1:41 PM CET
0.40%
Market Cap282.59M
Revenue (ttm)882.80M
Net Income (ttm)-124.30M
Shares Out95.21M
EPS (ttm)-1.31
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume37,506
Average Volume124,110
Open2.968
Previous Close2.968
Day's Range2.914 - 2.988
52-Week Range2.260 - 4.460
Beta0.69
RSI45.91
Earnings DateMar 3, 2026

About Euroapi

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances.... [Read more]

Sector Healthcare
Founded 2020
Employees 3,187
Stock Exchange Euronext Paris
Ticker Symbol EAPI
Full Company Profile

Financial Performance

In 2024, Euroapi's revenue was 919.20 million, a decrease of -9.79% compared to the previous year's 1.02 billion. Losses were -130.60 million, -31.15% less than in 2023.

Financial Statements